Rationalizing protein-ligand interactions for PTP1B inhibitors using computational methods.
about
Why Antidiabetic Vanadium Complexes are Not in the Pipeline of "Big Pharma" Drug Research? A Critical ReviewAnti-tubercular drug designing by structure based screening of combinatorial libraries.Synthesis, In Vivo Anti-Inflammatory Activity, and Molecular Docking Studies of New Isatin Derivatives.Computational revelation of binding mechanisms of inhibitors to endocellular protein tyrosine phosphatase 1B using molecular dynamics simulations.
P2860
Rationalizing protein-ligand interactions for PTP1B inhibitors using computational methods.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Rationalizing protein-ligand i ...... s using computational methods.
@en
Rationalizing protein-ligand i ...... s using computational methods.
@nl
type
label
Rationalizing protein-ligand i ...... s using computational methods.
@en
Rationalizing protein-ligand i ...... s using computational methods.
@nl
prefLabel
Rationalizing protein-ligand i ...... s using computational methods.
@en
Rationalizing protein-ligand i ...... s using computational methods.
@nl
P2093
P2860
P1476
Rationalizing protein-ligand i ...... s using computational methods.
@en
P2093
Subhash Ajmani
Sudheer Karanam
Sudhir A Kulkarni
P2860
P304
P356
10.1111/J.1747-0285.2009.00894.X
P577
2009-10-12T00:00:00Z